The investment includes six new U.S. sites by the end of 2022, which will all be fully licensed with temperature-controlled spaces that support pharmaceutical storage requirements.
“This latest investment in our life sciences and healthcare sector is testament to our track record and pedigree for delivering unrivaled supply chain expertise to our partners,” said Jim Saponaro, president of life sciences and healthcare at DHL Supply Chain North America. “This substantial expansion will only further deepen the connections between our customers and the patients they serve by providing best-in-class end-to-end supply chain solutions.”
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
